Gesynta Pharma has completed recruitment for its Phase 2 trial [...]

Oncodesign Services and Nexus BioQuest have formed a preclinical research [...]

Calla Lily Clinical Care has been selected for Wellcome Leap’s [...]

Medicus Pharma has received authorisation from the UAE Department of [...]

Seegene analysis of about 60,000 test results found STI pathogens [...]

The founder of the International Ovarian Tumor Analysis collaboration has [...]

ReproNovo has dosed the first participant in a European Phase [...]

Gesynta Pharma has randomised half of the planned patients in [...]

Medicus Pharma has submitted an investigational new drug application in [...]

Ultrahuman and Click Therapeutics have entered a partnership to develop [...]